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OBJECTIVES Diabetics with acute myocardial infarction (AMI) have a
higher risk of adverse outcomes because of complicated factors. Our
aim was to investigate the impact of diabetes on the long-term prog-
nosis in patients with non ST-elevation myocardial infarction
(NSTEMI) patients in the current era.
METHODS From 2002 to 2013, a total of 2080 patients diagnosed of
NSTEMI were retrospectively evaluated in the Cardiology Department
of the First Afﬁliated Hospital of Dalian Medical University. Uniﬁed
follow-up questionnaire was used to visit the NSTEMI patients by
telephone contact (cut-off date was October, 2014). We compared
hospital care data and prognosis between diabetic and nondiabetic
patients.
RESULTS Diabetic patients accounted for 38.6% (n¼803). Compared
with nondiabetic patients, Diabetic ones were more likely to be
older (71.0 vs. 67.0; P <0.001), female (47.6% vs. 29.8%; P <0.001),
and to have hypertension (80.4% vs.60.3%, P <0.001), prior cere-
brovascular disease (6.2% vs. 3.3%, P ¼0.002) and renal insufﬁ-
ciency (36.5% vs. 24.9%, P <0.001) and killip 3 (16.1% vs. 8.1,
P <0.001).
The median follow-up time was 3.1 years.. Diabetic patients showed
higher mortality (32.4% vs.20.9%; P <0.001 ) and secondary endpoint
(the composite end point) rates (52.4% vs. 40.7%; P <0.001) than
nondiabetic patients.
After controlling for other variables, diabetes was associated with
higher mortality (adjusted RR: 1.277; 95%CI: 1.035-1.575) and second-
ary endpoint rates (adjusted RR: 1.255; 95%CI: 1.081-1.458) (HR¼2.118,
95%CI: 1.572-2.854, P <0.001).
In the subgroup analysis according to percutaneous coronary
intervention (PCI), there were no differences in mortality (4.6% vs.
3.5%; P ¼0.475) and secondary endpoint rates (27.2% vs. 24.6%;
P ¼0.464) between diabetic and nondiabetic patients. After control-
ling for other variables, diabetes was no longer the independent risk
factor of mortality (adjusted RR: 1.468; 95CI: 0.664-3.244; P ¼0.342),
but the independent risk factor of secondary endpoint rates. (adjusted
RR: 1.492; 95%CI: 1.055-2.111; P ¼0.024).
CONCLUSIONS The diabetic patients with NSTEMI had worse prog-
nosis. However, PCI therapy narrowed the gap of the prognosis be-
tween diabetic and non-diabetic NSTEMI patients.GW26-e1312
Changes of Expression of HMGB1 Interferenced with atorvastatin in acute
ST-segment elevation myocardial infarction patients with 2-type Diabetes
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OBJECTIVES To observe atorvastatin mediated inﬂammatory factor
HMGB1 in patient of acute ST-segment elevation myocardial infarc-
tion with 2-type Diabetes.
METHODS 226 patients with consecutive elections ST-segment
elevation acute myocardial infarction with 2-type Diabetes were
collected from January 2008 to December 2014, aged 27-90 years old,
ruled out infectious diseases, cancer, collagen diseases, application of
immunosuppressive drugs. All patients underwent emergency coro-
nary intervention, were randomly divided into control group and
early intervention atorvastatin group (undergoing emergency percu-
taneous coronary intervention 30 minutes to 1 hour after oral
administration of atorvastatin 80mg), ELISA was used to measure the
contents of HMGB1.
RESULTS 1. The levels of HMGB1 in two groups increased 24 hours
after PCI ( P <0.01); 2. The levels of HMGB1 in the intervention group
was statistically signiﬁcant compared with the control group 24 hours
later.
CONCLUSIONS High-dose atorvastatin used i in patient of acute ST-
segment elevation myocardial infarction with 2-type Diabetes before
percutaneous coronary intervention promotes HMGB1 levels drop,
reduce inﬂammatory response in patients.GW26-e0198
The analysis of clinical characteristics of Debakey I aortic dissection Injury
the left main coronary artery
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OBJECTIVES Analysis the characteristics of Debakey I aortic dissec-
tion injury the left main coronary artery.
METHODS Collected the clinical data of patients in our hospital in
recent 5 years, diagnosed as Debakey I aortic dissection injured the
left main coronary artery, All patients through the aortic CTA
diagnosed.
RESULTS Debakey I aortic dissection injured the left main coronary
artery shows a typical ECG expression of the Coronary heart disease
with Left main coronary lesions, Confused easily with acute non ST
segment elevation myocardial infarction, But the age of onset of chest
pain is younger, more serious, often accompanied by backache,
careful physical examination can also ﬁnd hints of aortic dissection
information, besides, troponin levels, previous chest pain history and
ECG dynamic changes have certain difference.
CONCLUSIONS Debakey I aortic dissection is a critical cardiovascular
diseases, Often injured the right coronary artery, caused acute inferior
myocardial infarction. Left main coronary artery injured is rare but
very dangerous. And easily misdiagnosed as acute coronary syndrome
treated with serious consequences, ECG expression of the Coronary
heart disease with Left main coronary lesions Should exclude aortic
dissection Firstly.GW26-e1510
Approach of Determining Culprit Vessel in acute inferior myocardial
infarction by ECG
Chunlin Huang
Xinfeng County People Hospital
OBJECTIVES According to the indexes of electrocardiogram in the
patient who with acute inferior wall myocardial infarction, analyze
the judging process to identifying the Culprit Vessel.
METHODS 193 patient who with acute inferior myocardial infarction
were admitted into the study, According to the results of CAG divided
into RCA occlusion group and LCX occlusion group, Analysis the In-
dexes of ECG, summarize the diagnosis process of IRA.
RESULTS 1. The approach to determine RCA or LCX of culprit vessels:
step 1: ST[0.05mv in lead V4R or IIIAVB is a sign to identify RCA.
Step 2: STY0.05mv in lead I and AVL is a sign to identify RCA; ST[ or
equipotential line in lead I and AVL is a sign to identify LCX. Step 3:
ST[ in lead II /ST[in lead III 1 is a sign to identify LCX. Step 4: SSTY
in lead V1, V2 and V3/SST[ in lead II, III and AVF1 is a sign to identify
RCA; SSTY in lead V1, V2 and V3/SST[ in lead II, III and AVF>1 is a
sign to identify LCX.
CONCLUSIONS ECG analysis can determine the part of culprit vessel
in a rapid and accurate way.GW26-e1578
The glycated hemoglobin Alc (HbA1c) levels and the prognosis after PCI in
postmenopausal women with acute coronary syndrome and diabetes
Xin Zou, Peng Qu
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OBJECTIVES To explore the inﬂuence of glycated hemoglobin Alc
(HbA1c) levels on clinical outcomes in postmenopausal women with
acute coronary syndrome and diabetes after percutaneous coronary
intervention (PCI).
METHODS We selected 675 consecutive ﬁrst hospitalized patients
with acute coronary syndrome (ACS) during January 2008 to January
2013 in the hospital. All the patients were postmenopausal women
(55 years old) and preformed PCI treatment. According to HbA1c
levels and diagnosis of diabetes, patients were divided into 3 groups:
non-diabetics (A group, N¼373), good-control diabetics(B group,
HbA1c<7.0%, N¼75), poor-control diabetics (C group, HbA1c7.0%,
N¼154). Patients information was collecteded,12 hours of fasting pe-
ripheral venous blood was taken to detect glycated hemoglobin,
fasting blood glucose, blood lipids, etc. According to the image of
coronary artery angiography, the SYNTAX score was calculated, after
PCI the number and length of implanted stent was recorded. All
